image
Healthcare - Biotechnology - NASDAQ - US
$ 6.55
3.47 %
$ 956 M
Market Cap
-1.79
P/E
BALANCE SHEET
479 M ASSETS
-19.72%
77.9 M LIABILITIES
29.91%
401 M EQUITY
-25.27%
BALANCE SHEET DECOMPOSITION
Balance Sheet 89bio, Inc.
image
Current Assets 476 M
Cash & Short-Term Investments 440 M
Receivables 0
Other Current Assets 36.5 M
Non-Current Assets 2.24 M
Long-Term Investments 0
PP&E 1.6 M
Other Non-Current Assets 640 K
91.91 %7.62 %Total Assets$478.7m
Current Liabilities 36.1 M
Accounts Payable 15.4 M
Short-Term Debt 1.45 M
Other Current Liabilities 19.3 M
Non-Current Liabilities 41.8 M
Long-Term Debt 1.09 M
Other Non-Current Liabilities 40.7 M
19.75 %24.77 %52.22 %Total Liabilities$77.9m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 126.1 316.2 55.3 150.7 204.7 93.4 11.2
Short Term Investments 313.9 262.7 132.9 98.3 106.4 0 0
Receivables 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0
Other Current Assets 36.5 14.7 15.8 11.3 5.6 2.0 82 K
Total Current Assets 476.4 593.5 196.1 162.0 210.2 95.3 11.3
PP&E 1.6 2.3 0.5 0.1 0.2 0.2 33 K
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0
Other Long Term Assets 0.6 0.4 0.3 0.3 0.7 72 K 0
Other Assets 0 0 0 0 0 0 0
Total Assets 478.7 596.3 196.8 162.4 211.1 95.6 11.4
LIABILITIES
Accounts Payable 15.4 8.6 12.5 6.8 2.1 1.0 1.5
Short Term Debt 1.5 0.5 0.3 2.5 0 0 1.7
Other Current Liabilities 19.3 20.5 11.8 10.2 6.0 4.6 1.2
Total Current Liabilities 36.1 29.6 24.6 19.5 8.1 5.6 4.4
Long Term Debt 1.1 26.6 19.9 16.9 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 40.7 3.7 0.5 30 K 0 0 0
Total Liabilities 77.9 60.0 45.0 36.5 8.1 5.6 27.4
EQUITY
Common Stock 0.1 93 K 51 K 20 K 20 K 14 K 1 K
Retained Earnings (824.5) (457.4) (315.2) (213.2) (123.1) (73.6) (16.2)
Other Accumulative Comprehensive Income/Loss 0.6 0.2 (0.3) 64 K 10 K (95.6) 6 K
Total Equity 400.8 536.3 151.8 126.0 203.0 89.9 (16.1)
Total Liabilities and Equity 478.7 596.3 196.8 162.4 211.1 95.6 11.4
SHARES OUTSTANDING
Common Shares Outstanding 104.7 71.2 34.8 20.1 16.1 10.6 4.6